Over 40 Posters/Abstracts in Support of TREK Presented at the 2004 ECCMID

Similar documents
ORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

and Health Sciences, Wayne State University and Detroit Receiving Hospital, Detroit, MI, USA

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

European Committee on Antimicrobial Susceptibility Testing

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

What s new in EUCAST methods?

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system

Performance Information. Vet use only

European Committee on Antimicrobial Susceptibility Testing

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Marc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium

Antimicrobial susceptibility

ORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

In Vitro Evaluation of a Novel Ketolide Antimicrobial Agent, RU-64004

CONTAGIOUS COMMENTS Department of Epidemiology

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the Prospective European Surveillance Initiative

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Fluoroquinolones in 2007: the Angels, the Devils, and What Should the Clinician Do?

Available online at ISSN No:

Annual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

Should we test Clostridium difficile for antimicrobial resistance? by author

Intrinsic, implied and default resistance

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Antimicrobial susceptibility testing challenges. Linda Joyce St Vincent s Hospital Melbourne

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

EUCAST recommended strains for internal quality control

Samantha Trumm, Pharm.D. PGY-1 Resident Avera McKennan Hospital and University Center

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

ANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI

EUCAST-and CLSI potency NEO-SENSITABS

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs?

Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints

Antimicrobial Resistance Trends in the Province of British Columbia

Antimicrobial agents. are chemicals active against microorganisms

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Microbiology, Southmead Hospital, Southmead Road, Bristol BS10 5NB, UK

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

BSAC antimicrobial susceptibility

EUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

CONTAGIOUS COMMENTS Department of Epidemiology

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

on February 12, 2018 by guest

crossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-negative pathogens between

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

What s new and not so new on the antimicrobial horizon? G. L. French

Received: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008

Cipro for gram positive cocci in urine

ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

SUPPLEMENT ARTICLE. Michael A. Pfaller, David J. Farrell, Helio S. Sader, and Ronald N. Jones. JMI Laboratories, North Liberty, Iowa

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

INTRODUCTION. Keywords Antimicrobial resistance, respiratory tract pathogens, surveillance principles and practice, global situation

Tel: Fax:

SUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.

Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

A Norazah, M D*, V K E Lim, FRCPath**, MY Rohani, MPath*, A G M Kamel, MD**,

Principles of Antimicrobial Therapy

Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

ANTIMICROBIAL SUSCEPTIBILITY CONTEMPORARY SUSCEPTIBILITY TESTS AND TREATMENTS FOR VRE INFECTIONS

January 2014 Vol. 34 No. 1

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Pneumococcus: Antibiotic Resistance in the Region

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Background and Plan of Analysis

In Vivo Characterization of the Peptide Deformylase Inhibitor LBM415 in Murine Infection Models

Transcription:

Over 40 Posters/Abstracts in Support of TREK Presented at the ECCMID This was our best ECCMID ever for TREK presentations! The following posters and abstracts were in support of TREK products! Sensititre Clinical Susceptibility Testing 4 posters Anaerobe Susceptibility Testing 1 poster Fungal Susceptibility Testing 5 posters/1 abstract TB Testing 1 poster/1 abstract Surveillance and Clinical Trials (Frozen Plates) 5 posters Surveillance and Clinical Trails (Dried Plates) 19 posters/2 abstracts VersaTREK 1 poster/1 abstract For more information on these items, please scroll down Clinical Susceptibility Testing Sensititre P1621 (used Lab Services frozen panels) Smith Molland, E., et al. Evaluation of cefepime with and without clavulanic acid for the detection of extended spectrum beta-lactamase in Enterobacteriaceae species. 14 th ECCMID, Praha. Poster P1621. P1139 M. Monaco, et al. Evolution of Macrolide resistance in Streptococcus pneumoniae in Italy 14 th ECCMID, Praha. Poster P1139. P1753 Rennie R. et al. Comparison of Four commercially Available Systems for Antimicrobial Susceptibility Testing ( AST) of Streptococcus pneumoniae 14 th ECCMID, Praha. Poster P1753. P1868 Galani, I. et al The first identification of VIM-1 in an Enterobacter cloacae isolate from a university hospital in Greece. 14 th ECCMID, Praha. Poster P1868.. Anaerobe Susceptibility Testing P500 Alcalá, L et al.in vitro activity of 12 antimicrobic agents against clinical Bacteroides fragilis group strains isolated over a 7-month period. 14 th ECCMID, Praha. Poster P500. Fungal Susceptibility Testing P508 Yucesoy. M and C. Ergon. Comparative evaluation of AFST-EUCAST method and Sensititre YeastOne Colorimetric antifungal panel with NCCLS reference method for susceptibility testing of Candida species. 14 th ECCMID, Praha. Poster P508.

P512 Quindós, G., et al. In vitro activities of fluconazole and voriconazole against Spanish bloodstream isolates of Candida glabrata and Candida krusei. 14 th ECCMID, Praha. Poster P512. P999 Asticcioli, S. et al Recurrent vulvovaginal candidiasis: prevalence, antifungal susceptibility patterns and genotyping of different species 14 th ECCMID, Praha. Poster P999. P1472 Guinea, J. et al Fluconazole resistance mechanisms in C. krusei clinical isolates. The contribution of efflux pumps.14 th ECCMID, Praha. Poster P1472. O400 Espinal-Ingroff, A., S. Killian, C. Knapp and N. Holiday. Sensititre YeastOne Colorimetric Antifungal Plate for testing voriconazole against isolates of Candida species: a comparison with the NCCLS M27-A2 microdilution reference method. 14 th ECCMID, Praha. Abstract O400. Tb Testing P1896 Brimecombe, M., et al. Reproducibility of mycobacterium QC strains in the Sensititre rapid growing and slowly growing no tuberculosis mycobacteria broth microdilution susceptibility procedure. 14 th ECCMID, Praha. Poster P1896.. R1939 Brimecombe, M., T. Tiridani, R. Grist and N. Sullivan. Reproducibility of Sensititre M. tuberculosis broth microdilution susceptibility procedure. 14 th ECCMID, Praha. Abstract R1939.. Surveillance and Clinical Trials Frozen Plates P914 Jones, R., T. Fritsche and H. Sader. Antimicrobial spectrum and activity of NVP PDF-713 (PDF7), a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates 14 th ECCMID, Praha. Poster P914. P915 Ednie, L.M. Jacobs, M.R. Appelbaum, P. C. Antostaphylococcal Activity of LBM415, A New Peptide Deformylase Infhibitor, Compared to Other Agents. 14 th ECCMID, Praha. Poster P915. P918 Jones, R, Moet, G.J., H. Sader, and T. Fritsche Potential Utility of a Peptide Deformylase Inhibitor, LBM415, against Oxazolidine-Resistant or Streptogramin-Resistant Gram Positive Isolates. 14 th ECCMID, Praha. Poster P918. P919 Credito, K.L., Lin, G., Jacobs M.R., Appelbaum. Time-kill Study of the Antistaphylococcal Activity of LBM415 Compared to Other Agents. 14 th ECCMID, Praha. Poster P919. P923 Fritsche, T., T. Anderegg and R.Jones. Determination of quality control guidelines for MIC dilution and disk diffusion methods when testing NVP-PDF713, a novel peptide deformylase inhibitor. 14 th ECCMID, Praha. Poster P923.

Dried Plates P494 Morosini, M.I. et al. Assessment of in vitro telithromycin activity against recent Haemophilus influenzae isolates recoverd from adult patients in Spain. 14 th ECCMID, Praha. Poster P494. P522 Reinert,R., A Rodloff and D. Felmingham. Unchanged susceptibility of key respiratory pathogens to telithromycin post-introduction in Germany. 14 th ECCMID, Praha. Poster P522. P523 Sunakawa, K., D. Farrell (Kanagawa, JP:London,UK). Prevalence of antimicrobial resistance and activity of the ketolide telithromycin against Haemophilus influenzae isolated from Japanese children. 14 th ECCMID, Praha. Poster P523. P524 Latorre, C., C. Garcia-Rey, J. Barron, A. Pinedo, J.M. Nogueira, J. Torres and L. Aguilar- The Spanish Surveillance Group for Respiratory Pathogens. Susceptibility of recent pediatric respiratory isolates of Streptococcus pneumoniae and Haemophilus influenzae in Spain. 14 th ECCMID, Praha. Poster P524. P525 Garcia-Perea, A., C. Garcia-Rey, C. Garcia-Reistra, R. Lindinez, M. De-la-Rosa, P.Alomar, J. Garcia-de-Lomas and L. Aguilar- The Spanish Surveillence Group for Respiratory Pathogens. Susceptibility of Haemophilus influenzae respiratory isolates in adults in Spain (2001-2002). 14 th ECCMID, Praha. Poster P525. P527 Morressey,I., et al. The comparative in vitro activity of moxifloxacin against respiratory tract pathogens isolated during 2003 from Libra Targeted Surveillance. 14 th ECCMID, Praha. Poster P527. P924 Moet, G., R.Jones, P. Rhomberg and T. Fritsche and H. Sader. Determination of dry-form commercial reagent reproducibility and MIC validations for NVP PDF713, a novel peptide deformylase inhibitor. 14 th ECCMID, Praha. Poster P924. P936 Jones, R., T. Fritsche and H. Sader. Evaluations of Dalbavancin activity and spectrum tested against European isolates. 14 th ECCMID, Praha. Poster P936. P937 Fritsche, T., H. Sader, J. Kirby and R. Jones. In vitro activity of the glycylcycline tigecycline tested against a worldwide collection of 10,127 contemporary staphylococci, streptococci and enterococci. 14 th ECCMID, Praha. Poster P937. P939 Jones, R., T. Fritsche, H. Sader and M. Beach. Antimicrobial activity of tigecycline ( GAR-936) tested against enterobactericaeae and selected non-fermentative Gram-negative bacilli, a worldwide sample. 14 th ECCMID, Praha. Poster P939.

P940 Sader, H., T. Fritsche, J. Kirby and R.Jones. Antimicrobial activity of tigecycline tested against clinical isolates of Haemophilus influenzae, Moraxella catarrhalis and Neisseria meningitidis, a worldwide sample. 14 th ECCMID, Praha. Poster P939. P1088 Reinert, R., D. Felmingham. Susceptibility of Streptococcus pyogenes to telithromycin and erythromycin: results from PROTEKT (Years 1-3). 14 th ECCMID, Praha. Poster P1088. P1091 Perez-Trallero E., et al. Large differences in resistance to erythromycin in Streptococcus pyogenes isolates of pharyngitis among regions of Spain. 14 th ECCMID, Praha. Poster P1091. P1128 Speciale, A. Prevalence and antibiotic resistance of the most important urinary pathogens responsible for non- complicated cystitis in women: the icea 2 Study. 14 th ECCMID, Praha. Poster P1128. P1135 Gobernado, M., et al. Susceptibility of Streptococcus pneumoniae respiratory isolates from adults in Spain (2001-2002). 14 th ECCMID, Praha. Poster P1135. P1148 Farrell and I. Morrissey. Distribution of macrolide resistance mechanisms in Streptococcus pneumoniae: 3-year update from the PROTEKT study. 14 th ECCMID, Praha. Poster P1148.. P1149 Schito, G., D. Felmingham. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2002) 14 th ECCMID, Praha. Poster P1149.. P1153 Mendes, C., et al. Antimicrobial resistance among community-acquired respiratory tract infections in Brazil: PROTEKT 2002. 14 th ECCMID, Praha. Poster P1153.. P1465 Farrell, D., I. Morrissey, S. Bakker and D. Felmingham. Mutations in erm (B) associated with rare, low level telithromycin resistance in Streptococcus pneumoniae: 3 year data from PROTEKT. 14 th ECCMID, Praha. Poster P1465.. R1988 Morrissey, I., et al. The comparative in vitro activity of ciprofloxacin against urinary-tract pathogens isolated from Europe during 2003 from Libra Targeted Surveillance. 14 th ECCMID, Praha. Abstract R1988.. R2072 Gianneli, D. et al. Emerging antimicrobial resistance in bacterial strains isloated from intensive care unit patients with bacteraemia. 14 th ECCMID, Praha. Abstract R2072..

VersaTREK P1658 La Bombardi, V. et al Comparison of the VersaTREK to the ESP Culture System 11 for blood cultures. 14 th ECCMID, Praha. Poster P1658.. R2345 La Bombardi, V. et al Comparison of the VersaTREK to the ESP Culture System 11 for mycobacterial detection and susceptibility testing.14 th ECCMID, Praha. Abstract R2345.. For more information on ECCMID, visit www.escmid.org